NCT03688542View on ClinicalTrials.gov

Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 25, 2017

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2020

Conditions
PolypharmacyInappropriate Prescribing
Interventions
OTHER

Quality Circle Deprescribing Module

The Quality Circle Deprescribing Module consist of a discussion bringing together nurses, physicians and responsible pharmacist to create a local deprescribing consensus for frequently used drug classes, as well as implementation strategies for the consensus..

Trial Locations (1)

1011

Centre de Pharamacie Communautaire, Lausanne

All Listed Sponsors
lead

Anne Niquille

OTHER

NCT03688542 - Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module | Biotech Hunter | Biotech Hunter